Table of Content

1 Study Coverage
1.1 PD-1 and PD-L1 Drug Product Introduction
1.2 Global PD-1 and PD-L1 Drug Outlook 2018 VS 2024 VS 2034
1.2.1 Global PD-1 and PD-L1 Drug Sales in US$ Million for the Year 2018-2034
1.2.2 Global PD-1 and PD-L1 Drug Sales in Volume for the Year 2018-2034
1.3 India PD-1 and PD-L1 Drug Outlook 2018 VS 2024 VS 2034
1.3.1 India PD-1 and PD-L1 Drug Sales in US$ Million for the Year 2018-2034
1.3.2 India PD-1 and PD-L1 Drug Sales in Volume for the Year 2018-2034
1.4 PD-1 and PD-L1 Drug Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of India PD-1 and PD-L1 Drug in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of PD-1 and PD-L1 Drug Market Size, India VS Global, 2018 VS 2024 VS 2034
1.5 PD-1 and PD-L1 Drug Market Dynamics
1.5.1 PD-1 and PD-L1 Drug Industry Trends
1.5.2 PD-1 and PD-L1 Drug Market Drivers
1.5.3 PD-1 and PD-L1 Drug Market Challenges
1.5.4 PD-1 and PD-L1 Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 PD-1 and PD-L1 Drug by Type
2.1 PD-1 and PD-L1 Drug Market Segment by Type
2.1.1 PD-1 Monoclonal Antibody
2.1.2 PD-L1 Monoclonal Antibody
2.2 Global PD-1 and PD-L1 Drug Market Size by Type
2.2.1 Global PD-1 and PD-L1 Drug Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global PD-1 and PD-L1 Drug Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global PD-1 and PD-L1 Drug Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 India PD-1 and PD-L1 Drug Market Size by Type
2.3.1 India PD-1 and PD-L1 Drug Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 India PD-1 and PD-L1 Drug Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 India PD-1 and PD-L1 Drug Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 PD-1 and PD-L1 Drug by Application
3.1 PD-1 and PD-L1 Drug Market Segment by Application
3.1.1 Liver Cancer
3.1.2 Esophageal Cancer
3.1.3 Nasal Cancer
3.1.4 Stomach Cancer
3.1.5 Other
3.2 Global PD-1 and PD-L1 Drug Market Size by Application
3.2.1 Global PD-1 and PD-L1 Drug Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global PD-1 and PD-L1 Drug Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global PD-1 and PD-L1 Drug Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 India PD-1 and PD-L1 Drug Market Size by Application
3.3.1 India PD-1 and PD-L1 Drug Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 India PD-1 and PD-L1 Drug Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 India PD-1 and PD-L1 Drug Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global PD-1 and PD-L1 Drug Competitor Landscape by Company
4.1 Global PD-1 and PD-L1 Drug Market Size by Company
4.1.1 Global Key Manufacturers of PD-1 and PD-L1 Drug, Ranked by Revenue (2024)
4.1.2 Global PD-1 and PD-L1 Drug Revenue by Manufacturer (2018-2023)
4.1.3 Global PD-1 and PD-L1 Drug Sales by Manufacturer (2018-2023)
4.1.4 Global PD-1 and PD-L1 Drug Price by Manufacturer (2018-2023)
4.2 Global PD-1 and PD-L1 Drug Concentration Ratio (CR)
4.2.1 PD-1 and PD-L1 Drug Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of PD-1 and PD-L1 Drug in 2024
4.2.3 Global PD-1 and PD-L1 Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of PD-1 and PD-L1 Drug, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of PD-1 and PD-L1 Drug, Product Offered and Application
4.5 Global Key Manufacturers of PD-1 and PD-L1 Drug, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India PD-1 and PD-L1 Drug Market Size by Company
4.7.1 Key Players of PD-1 and PD-L1 Drug in India, Ranked by Revenue (2024)
4.7.2 India PD-1 and PD-L1 Drug Revenue by Players (2018-2023)
4.7.3 India PD-1 and PD-L1 Drug Sales by Players (2018-2023)
5 Global PD-1 and PD-L1 Drug Market Size by Region
5.1 Global PD-1 and PD-L1 Drug Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global PD-1 and PD-L1 Drug Market Size in Volume by Region (2018-2034)
5.2.1 Global PD-1 and PD-L1 Drug Sales in Volume by Region: 2018-2023
5.2.2 Global PD-1 and PD-L1 Drug Sales in Volume Forecast by Region (2024-2034)
5.3 Global PD-1 and PD-L1 Drug Market Size in Value by Region (2018-2034)
5.3.1 Global PD-1 and PD-L1 Drug Sales in Value by Region: 2018-2023
5.3.2 Global PD-1 and PD-L1 Drug Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas PD-1 and PD-L1 Drug Market Size YoY Growth 2018-2034
6.2 Americas PD-1 and PD-L1 Drug Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas PD-1 and PD-L1 Drug Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas PD-1 and PD-L1 Drug Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas PD-1 and PD-L1 Drug Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas PD-1 and PD-L1 Drug Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA PD-1 and PD-L1 Drug Market Size YoY Growth 2018-2034
7.2 EMEA PD-1 and PD-L1 Drug Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA PD-1 and PD-L1 Drug Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA PD-1 and PD-L1 Drug Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA PD-1 and PD-L1 Drug Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA PD-1 and PD-L1 Drug Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China PD-1 and PD-L1 Drug Market Size YoY Growth 2018-2034
8.2 China PD-1 and PD-L1 Drug Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China PD-1 and PD-L1 Drug Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC PD-1 and PD-L1 Drug Market Size YoY Growth 2018-2034
9.2 APAC PD-1 and PD-L1 Drug Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC PD-1 and PD-L1 Drug Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC PD-1 and PD-L1 Drug Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC PD-1 and PD-L1 Drug Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC PD-1 and PD-L1 Drug Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Bristol Myers Squibb
10.1.1 Bristol Myers Squibb Company Information
10.1.2 Bristol Myers Squibb Description and Business Overview
10.1.3 Bristol Myers Squibb PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bristol Myers Squibb PD-1 and PD-L1 Drug Products Offered
10.1.5 Bristol Myers Squibb Recent Development
10.2 Merck & Co., Inc.
10.2.1 Merck & Co., Inc. Company Information
10.2.2 Merck & Co., Inc. Description and Business Overview
10.2.3 Merck & Co., Inc. PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck & Co., Inc. PD-1 and PD-L1 Drug Products Offered
10.2.5 Merck & Co., Inc. Recent Development
10.3 F. Hoffmann -La Roche Ltd
10.3.1 F. Hoffmann -La Roche Ltd Company Information
10.3.2 F. Hoffmann -La Roche Ltd Description and Business Overview
10.3.3 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Products Offered
10.3.5 F. Hoffmann -La Roche Ltd Recent Development
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information
10.4.2 AstraZeneca Description and Business Overview
10.4.3 AstraZeneca PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 AstraZeneca PD-1 and PD-L1 Drug Products Offered
10.4.5 AstraZeneca Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 Sanofi Description and Business Overview
10.5.3 Sanofi PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sanofi PD-1 and PD-L1 Drug Products Offered
10.5.5 Sanofi Recent Development
10.6 Pfizer Inc
10.6.1 Pfizer Inc Company Information
10.6.2 Pfizer Inc Description and Business Overview
10.6.3 Pfizer Inc PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Pfizer Inc PD-1 and PD-L1 Drug Products Offered
10.6.5 Pfizer Inc Recent Development
10.7 Lilly
10.7.1 Lilly Company Information
10.7.2 Lilly Description and Business Overview
10.7.3 Lilly PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Lilly PD-1 and PD-L1 Drug Products Offered
10.7.5 Lilly Recent Development
10.8 Novartis AG
10.8.1 Novartis AG Company Information
10.8.2 Novartis AG Description and Business Overview
10.8.3 Novartis AG PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Novartis AG PD-1 and PD-L1 Drug Products Offered
10.8.5 Novartis AG Recent Development
10.9 GSK
10.9.1 GSK Company Information
10.9.2 GSK Description and Business Overview
10.9.3 GSK PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 GSK PD-1 and PD-L1 Drug Products Offered
10.9.5 GSK Recent Development
10.10 Junshi Biosciences
10.10.1 Junshi Biosciences Company Information
10.10.2 Junshi Biosciences Description and Business Overview
10.10.3 Junshi Biosciences PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Junshi Biosciences PD-1 and PD-L1 Drug Products Offered
10.10.5 Junshi Biosciences Recent Development
10.11 Akeso, Inc
10.11.1 Akeso, Inc Company Information
10.11.2 Akeso, Inc Description and Business Overview
10.11.3 Akeso, Inc PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Akeso, Inc PD-1 and PD-L1 Drug Products Offered
10.11.5 Akeso, Inc Recent Development
10.12 BeiGene
10.12.1 BeiGene Company Information
10.12.2 BeiGene Description and Business Overview
10.12.3 BeiGene PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 BeiGene PD-1 and PD-L1 Drug Products Offered
10.12.5 BeiGene Recent Development
10.13 Innovent
10.13.1 Innovent Company Information
10.13.2 Innovent Description and Business Overview
10.13.3 Innovent PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Innovent PD-1 and PD-L1 Drug Products Offered
10.13.5 Innovent Recent Development
10.14 Jiangsu Hengrui Medicine Co.,Ltd
10.14.1 Jiangsu Hengrui Medicine Co.,Ltd Company Information
10.14.2 Jiangsu Hengrui Medicine Co.,Ltd Description and Business Overview
10.14.3 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Products Offered
10.14.5 Jiangsu Hengrui Medicine Co.,Ltd Recent Development
10.15 Cstone
10.15.1 Cstone Company Information
10.15.2 Cstone Description and Business Overview
10.15.3 Cstone PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Cstone PD-1 and PD-L1 Drug Products Offered
10.15.5 Cstone Recent Development
10.16 Henlius
10.16.1 Henlius Company Information
10.16.2 Henlius Description and Business Overview
10.16.3 Henlius PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Henlius PD-1 and PD-L1 Drug Products Offered
10.16.5 Henlius Recent Development
10.17 Simcere Pharmaceutical Group Limited
10.17.1 Simcere Pharmaceutical Group Limited Company Information
10.17.2 Simcere Pharmaceutical Group Limited Description and Business Overview
10.17.3 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Products Offered
10.17.5 Simcere Pharmaceutical Group Limited Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 PD-1 and PD-L1 Drug Industry Chain Analysis
11.2 PD-1 and PD-L1 Drug Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 PD-1 and PD-L1 Drug Production Mode & Process
11.4 PD-1 and PD-L1 Drug Sales and Marketing
11.4.1 PD-1 and PD-L1 Drug Sales Channels
11.4.2 PD-1 and PD-L1 Drug Distributors
11.5 PD-1 and PD-L1 Drug Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. PD-1 and PD-L1 Drug CAGR in Value, India VS Global, 2018 VS 2024 VS 2034
Table 2. PD-1 and PD-L1 Drug Market Trends
Table 3. PD-1 and PD-L1 Drug Market Drivers
Table 4. PD-1 and PD-L1 Drug Market Challenges
Table 5. PD-1 and PD-L1 Drug Market Restraints
Table 6. Global PD-1 and PD-L1 Drug Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India PD-1 and PD-L1 Drug Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global PD-1 and PD-L1 Drug Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India PD-1 and PD-L1 Drug Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of PD-1 and PD-L1 Drug, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global PD-1 and PD-L1 Drug Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global PD-1 and PD-L1 Drug Revenue Share by Manufacturer, 2018-2023
Table 13. Global PD-1 and PD-L1 Drug Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global PD-1 and PD-L1 Drug Sales Share by Manufacturer, 2018-2023
Table 15. Global PD-1 and PD-L1 Drug Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global PD-1 and PD-L1 Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global PD-1 and PD-L1 Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Drug as of 2024)
Table 18. Global Key Manufacturers of PD-1 and PD-L1 Drug, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of PD-1 and PD-L1 Drug, Product Offered and Application
Table 20. Global Key Manufacturers of PD-1 and PD-L1 Drug, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of PD-1 and PD-L1 Drug in India, Ranked by Revenue (2024) & (US$ million)
Table 23. India PD-1 and PD-L1 Drug Revenue by Players, (US$ Million), (2018-2023)
Table 24. India PD-1 and PD-L1 Drug Revenue Share by Players, (2018-2023)
Table 25. India PD-1 and PD-L1 Drug Sales by Players, (K Units), (2018-2023)
Table 26. India PD-1 and PD-L1 Drug Sales Share by Players, (2018-2023)
Table 27. Global PD-1 and PD-L1 Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global PD-1 and PD-L1 Drug Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global PD-1 and PD-L1 Drug Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global PD-1 and PD-L1 Drug Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global PD-1 and PD-L1 Drug Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas PD-1 and PD-L1 Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas PD-1 and PD-L1 Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas PD-1 and PD-L1 Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas PD-1 and PD-L1 Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas PD-1 and PD-L1 Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA PD-1 and PD-L1 Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA PD-1 and PD-L1 Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA PD-1 and PD-L1 Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA PD-1 and PD-L1 Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA PD-1 and PD-L1 Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC PD-1 and PD-L1 Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC PD-1 and PD-L1 Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC PD-1 and PD-L1 Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC PD-1 and PD-L1 Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC PD-1 and PD-L1 Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Bristol Myers Squibb Company Information
Table 48. Bristol Myers Squibb Description and Business Overview
Table 49. Bristol Myers Squibb PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Bristol Myers Squibb PD-1 and PD-L1 Drug Product
Table 51. Bristol Myers Squibb Recent Development
Table 52. Merck & Co., Inc. Company Information
Table 53. Merck & Co., Inc. Description and Business Overview
Table 54. Merck & Co., Inc. PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Merck & Co., Inc. PD-1 and PD-L1 Drug Product
Table 56. Merck & Co., Inc. Recent Development
Table 57. F. Hoffmann -La Roche Ltd Company Information
Table 58. F. Hoffmann -La Roche Ltd Description and Business Overview
Table 59. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Product
Table 61. F. Hoffmann -La Roche Ltd Recent Development
Table 62. AstraZeneca Company Information
Table 63. AstraZeneca Description and Business Overview
Table 64. AstraZeneca PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. AstraZeneca PD-1 and PD-L1 Drug Product
Table 66. AstraZeneca Recent Development
Table 67. Sanofi Company Information
Table 68. Sanofi Description and Business Overview
Table 69. Sanofi PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Sanofi PD-1 and PD-L1 Drug Product
Table 71. Sanofi Recent Development
Table 72. Pfizer Inc Company Information
Table 73. Pfizer Inc Description and Business Overview
Table 74. Pfizer Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Pfizer Inc PD-1 and PD-L1 Drug Product
Table 76. Pfizer Inc Recent Development
Table 77. Lilly Company Information
Table 78. Lilly Description and Business Overview
Table 79. Lilly PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Lilly PD-1 and PD-L1 Drug Product
Table 81. Lilly Recent Development
Table 82. Novartis AG Company Information
Table 83. Novartis AG Description and Business Overview
Table 84. Novartis AG PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Novartis AG PD-1 and PD-L1 Drug Product
Table 86. Novartis AG Recent Development
Table 87. GSK Company Information
Table 88. GSK Description and Business Overview
Table 89. GSK PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. GSK PD-1 and PD-L1 Drug Product
Table 91. GSK Recent Development
Table 92. Junshi Biosciences Company Information
Table 93. Junshi Biosciences Description and Business Overview
Table 94. Junshi Biosciences PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Junshi Biosciences PD-1 and PD-L1 Drug Product
Table 96. Junshi Biosciences Recent Development
Table 97. Akeso, Inc Company Information
Table 98. Akeso, Inc Description and Business Overview
Table 99. Akeso, Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Akeso, Inc PD-1 and PD-L1 Drug Product
Table 101. Akeso, Inc Recent Development
Table 102. BeiGene Company Information
Table 103. BeiGene Description and Business Overview
Table 104. BeiGene PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. BeiGene PD-1 and PD-L1 Drug Product
Table 106. BeiGene Recent Development
Table 107. Innovent Company Information
Table 108. Innovent Description and Business Overview
Table 109. Innovent PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Innovent PD-1 and PD-L1 Drug Product
Table 111. Innovent Recent Development
Table 112. Jiangsu Hengrui Medicine Co.,Ltd Company Information
Table 113. Jiangsu Hengrui Medicine Co.,Ltd Description and Business Overview
Table 114. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Product
Table 116. Jiangsu Hengrui Medicine Co.,Ltd Recent Development
Table 117. Cstone Company Information
Table 118. Cstone Description and Business Overview
Table 119. Cstone PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Cstone PD-1 and PD-L1 Drug Product
Table 121. Cstone Recent Development
Table 122. Henlius Company Information
Table 123. Henlius Description and Business Overview
Table 124. Henlius PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Henlius PD-1 and PD-L1 Drug Product
Table 126. Henlius Recent Development
Table 127. Simcere Pharmaceutical Group Limited Company Information
Table 128. Simcere Pharmaceutical Group Limited Description and Business Overview
Table 129. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Product
Table 131. Simcere Pharmaceutical Group Limited Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. PD-1 and PD-L1 Drug Customers List
Table 135. PD-1 and PD-L1 Drug Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. PD-1 and PD-L1 Drug Product Picture
Figure 2. Global PD-1 and PD-L1 Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global PD-1 and PD-L1 Drug Market Size 2018-2034 (US$ Million)
Figure 4. Global PD-1 and PD-L1 Drug Sales 2018-2034 (K Units)
Figure 5. India PD-1 and PD-L1 Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. India PD-1 and PD-L1 Drug Market Size 2018-2034 (US$ Million)
Figure 7. India PD-1 and PD-L1 Drug Sales 2018-2034 (K Units)
Figure 8. India PD-1 and PD-L1 Drug Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. India PD-1 and PD-L1 Drug Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. PD-1 and PD-L1 Drug Report Years Considered
Figure 11. Product Picture of PD-1 Monoclonal Antibody
Figure 12. Product Picture of PD-L1 Monoclonal Antibody
Figure 13. Global PD-1 and PD-L1 Drug Market Share by Type in 2024 & 2034
Figure 14. Global PD-1 and PD-L1 Drug Sales in Value by Type (2018-2034) & (US$ Million)
Figure 15. Global PD-1 and PD-L1 Drug Sales Market Share in Value by Type (2018-2034)
Figure 16. Global PD-1 and PD-L1 Drug Sales by Type (2018-2034) & (K Units)
Figure 17. Global PD-1 and PD-L1 Drug Sales Market Share in Volume by Type (2018-2034)
Figure 18. Global PD-1 and PD-L1 Drug Price by Type (2018-2034) & (US$/Unit)
Figure 19. India PD-1 and PD-L1 Drug Market Share by Type in 2024 & 2034
Figure 20. India PD-1 and PD-L1 Drug Sales in Value by Type (2018-2034) & (US$ Million)
Figure 21. India PD-1 and PD-L1 Drug Sales Market Share in Value by Type (2018-2034)
Figure 22. India PD-1 and PD-L1 Drug Sales by Type (2018-2034) & (K Units)
Figure 23. India PD-1 and PD-L1 Drug Sales Market Share in Volume by Type (2018-2034)
Figure 24. India PD-1 and PD-L1 Drug Price by Type (2018-2034) & (US$/Unit)
Figure 25. Product Picture of Liver Cancer
Figure 26. Product Picture of Esophageal Cancer
Figure 27. Product Picture of Nasal Cancer
Figure 28. Product Picture of Stomach Cancer
Figure 29. Product Picture of Other
Figure 30. Global PD-1 and PD-L1 Drug Market Share by Application in 2024 & 2034
Figure 31. Global PD-1 and PD-L1 Drug Sales in Value by Application (2018-2034) & (US$ Million)
Figure 32. Global PD-1 and PD-L1 Drug Sales Market Share in Value by Application (2018-2034)
Figure 33. Global PD-1 and PD-L1 Drug Sales by Application (2018-2034) & (K Units)
Figure 34. Global PD-1 and PD-L1 Drug Sales Market Share in Volume by Application (2018-2034)
Figure 35. Global PD-1 and PD-L1 Drug Price by Application (2018-2034) & (US$/Unit)
Figure 36. India PD-1 and PD-L1 Drug Market Share by Application in 2024 & 2034
Figure 37. India PD-1 and PD-L1 Drug Sales in Value by Application (2018-2034) & (US$ Million)
Figure 38. India PD-1 and PD-L1 Drug Sales Market Share in Value by Application (2018-2034)
Figure 39. India PD-1 and PD-L1 Drug Sales by Application (2018-2034) & (K Units)
Figure 40. India PD-1 and PD-L1 Drug Sales Market Share in Volume by Application (2018-2034)
Figure 41. India PD-1 and PD-L1 Drug Price by Application (2018-2034) & (US$/Unit)
Figure 42. Americas PD-1 and PD-L1 Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 43. Americas PD-1 and PD-L1 Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 44. Americas PD-1 and PD-L1 Drug Sales by Type (2018-2034) & (K Units)
Figure 45. Americas PD-1 and PD-L1 Drug Sales Market Share in Volume by Type (2018-2034)
Figure 46. Americas PD-1 and PD-L1 Drug Sales by Application (2018-2034) & (K Units)
Figure 47. Americas PD-1 and PD-L1 Drug Sales Market Share in Volume by Application (2018-2034)
Figure 48. United States PD-1 and PD-L1 Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Canada PD-1 and PD-L1 Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. Mexico PD-1 and PD-L1 Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. Brazil PD-1 and PD-L1 Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 52. EMEA PD-1 and PD-L1 Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 53. EMEA PD-1 and PD-L1 Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 54. EMEA PD-1 and PD-L1 Drug Sales by Type (2018-2034) & (K Units)
Figure 55. EMEA PD-1 and PD-L1 Drug Sales Market Share in Volume by Type (2018-2034)
Figure 56. EMEA PD-1 and PD-L1 Drug Sales by Application (2018-2034) & (K Units)
Figure 57. EMEA PD-1 and PD-L1 Drug Sales Market Share in Volume by Application (2018-2034)
Figure 58. Europe PD-1 and PD-L1 Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. Middle East PD-1 and PD-L1 Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 60. Africa PD-1 and PD-L1 Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 61. China PD-1 and PD-L1 Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 62. China PD-1 and PD-L1 Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 63. China PD-1 and PD-L1 Drug Sales by Type (2018-2034) & (K Units)
Figure 64. China PD-1 and PD-L1 Drug Sales Market Share in Volume by Type (2018-2034)
Figure 65. China PD-1 and PD-L1 Drug Sales by Application (2018-2034) & (K Units)
Figure 66. China PD-1 and PD-L1 Drug Sales Market Share in Volume by Application (2018-2034)
Figure 67. APAC PD-1 and PD-L1 Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 68. APAC PD-1 and PD-L1 Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 69. APAC PD-1 and PD-L1 Drug Sales by Type (2018-2034) & (K Units)
Figure 70. APAC PD-1 and PD-L1 Drug Sales Market Share in Volume by Type (2018-2034)
Figure 71. APAC PD-1 and PD-L1 Drug Sales by Application (2018-2034) & (K Units)
Figure 72. APAC PD-1 and PD-L1 Drug Sales Market Share in Volume by Application (2018-2034)
Figure 73. Japan PD-1 and PD-L1 Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. South Korea PD-1 and PD-L1 Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. China Taiwan PD-1 and PD-L1 Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. Southeast Asia PD-1 and PD-L1 Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. India PD-1 and PD-L1 Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 78. PD-1 and PD-L1 Drug Value Chain
Figure 79. PD-1 and PD-L1 Drug Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed